Literature DB >> 18806987

[Stent-assisted angioplasty for atherosclerotic stenosis of the carotid artery. An overview].

T Boeckh-Behrens1, H Brückmann.   

Abstract

For symptomatic stenosis of the carotid artery the invasive options for treatment (by means of stent or operation) are superior to conservative medical treatment. Recent multi-center randomized controlled trials, which will be presented here, indicate that stenting in the treatment of symptomatic carotid stenosis is neither safer nor more effective than carotid endarterectomy. When carried out by an experienced interventionalist stent-assisted angioplasty (CAS) is an alternative to carotid endarterectomy. Subgroup-analysis indicates that for patients older than 70 years of age invasive techniques should be the method of choice. In the case of contralateral high-grade stenosis or occlusion, CAS is the method of choice. For patients treated by stenting, the periprocedural complication rate is not influenced by the use of protection systems. The present results on symptomatic carotid stenosis should not be transferred to the therapy of asymptomatic carotid stenosis. A 3-armed study (SPACE2) on the comparison of the best medical treatment with the invasive treatment modalities (CAS or CEA) is in preparation and will be started in 2 months.

Entities:  

Mesh:

Year:  2008        PMID: 18806987     DOI: 10.1007/s00117-008-1710-1

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  27 in total

1.  Carotid angioplasty and stenting versus carotid endarterectomy for treatment of asymptomatic carotid stenosis: a randomized trial in a community hospital.

Authors:  William H Brooks; Rick R McClure; Michael R Jones; Timothy L Coleman; Linda Breathitt
Journal:  Neurosurgery       Date:  2004-02       Impact factor: 4.654

2.  Carotid endarterectomy.

Authors:  H J M Barnett
Journal:  Lancet       Date:  2004-05-08       Impact factor: 79.321

3.  Carotid stenting with distal protection in high surgical risk patients: the BEACH trial 30 day results.

Authors:  Christopher J White; Sriram S Iyer; L Nelson Hopkins; Barry T Katzen; Mary E Russell
Journal:  Catheter Cardiovasc Interv       Date:  2006-04       Impact factor: 2.692

4.  Stent-protected angioplasty versus carotid endarterectomy in patients with carotid artery stenosis: meta-analysis of randomized trial data.

Authors:  Martin Wiesmann; Veronika Schöpf; Olav Jansen; Hartmut Brückmann
Journal:  Eur Radiol       Date:  2008-07-25       Impact factor: 5.315

5.  Randomized study of carotid angioplasty and stenting versus carotid endarterectomy: a stopped trial.

Authors:  A R Naylor; A Bolia; R J Abbott; I F Pye; J Smith; N Lennard; A J Lloyd; N J London; P R Bell
Journal:  J Vasc Surg       Date:  1998-08       Impact factor: 4.268

Review 6.  Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: a systematic review of the literature.

Authors:  Andreas Kastrup; Klaus Gröschel; Hilmar Krapf; Bernhard R Brehm; Johannes Dichgans; Jörg B Schulz
Journal:  Stroke       Date:  2003-02-13       Impact factor: 7.914

7.  Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial.

Authors: 
Journal:  Lancet       Date:  2001-06-02       Impact factor: 79.321

8.  Carotid angioplasty and stenting versus carotid endarterectomy: randomized trial in a community hospital.

Authors:  W H Brooks; R R McClure; M R Jones; T C Coleman; L Breathitt
Journal:  J Am Coll Cardiol       Date:  2001-11-15       Impact factor: 24.094

9.  Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial.

Authors:  A Halliday; A Mansfield; J Marro; C Peto; R Peto; J Potter; D Thomas
Journal:  Lancet       Date:  2004-05-08       Impact factor: 79.321

10.  Carotid stenting with a new system for distal embolic protection and stenting in high-risk patients: the carotid revascularization with ev3 arterial technology evolution (CREATE) feasibility trial.

Authors:  Robert D Safian; J Michael Bacharach; Gary M Ansel; Frank J Criado
Journal:  Catheter Cardiovasc Interv       Date:  2004-09       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.